Cargando…

Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis

To evaluate the effect of glandular differentiation (GD) on tumor recurrence and progression of pT1 bladder urothelial carcinoma (UC). We performed a retrospective analysis of 82 bladder urothelial carcinoma with glandular differentiation (UCGD) patients which was pathologically diagnosed as pT1, 16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Guobin, Wang, Chao, Tang, Yuhong, Liu, Xin, Liu, Zihao, Li, Gang, Mei, Yanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441090/ https://www.ncbi.nlm.nih.gov/pubmed/30926888 http://dx.doi.org/10.1038/s41598-019-41844-4

Ejemplares similares

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017)

Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer
por: Li, Gang, et al.
Publicado: (2016)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection
por: Luo, Qiang, et al.
Publicado: (2020)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation
por: Wang, Tao, et al.
Publicado: (2022)

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
por: Liu, Jian-Ye, et al.
Publicado: (2013)

Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma
por: Lockhart, Kathleen, et al.
Publicado: (2021)

Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis
por: Guo, Rui, et al.
Publicado: (2023)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration
por: Zhou, Zhongbao, et al.
Publicado: (2022)

Impact of Squamous and Glandular Differentiation on Oncologic Outcomes in Upper and Lower Tract Urothelial Carcinoma
por: Lee, Young Ju, et al.
Publicado: (2014)

Differentiation of Urothelial Carcinoma into Two Distinct Subtypes, Glandular and Squamous, in Three Different Organs
por: El-Asmar, Jose M, et al.
Publicado: (2020)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma
por: Wang, Haiping, et al.
Publicado: (2017)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma
por: Lin, Bo, et al.
Publicado: (2020)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
por: Li, Gang, et al.
Publicado: (2017)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
por: Al-Maghrabi, Basim, et al.
Publicado: (2019)

Successful Treatment with Paclitaxel, Carboplatin, and Gemcitabine as Second-line Chemotherapy for Recurrent Urothelial Carcinoma of the Bladder with Glandular Differentiation After Radical Cystectomy: A Case Report
por: Fukuhara, Hiroki, et al.
Publicado: (2017)

AB121. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy
por: Tang, Qi, et al.
Publicado: (2015)

Comparative genomic profiling of glandular bladder tumours
por: Maurer, Angela, et al.
Publicado: (2020)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
por: Kerzeli, Iliana K., et al.
Publicado: (2023)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
por: Ning, Xin, et al.
Publicado: (2017)

High CD204(+) tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder
por: Wang, Bo, et al.
Publicado: (2015)

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2015)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023)

ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
por: Balbás-Martínez, Cristina, et al.
Publicado: (2013)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Do histological variants in urothelial carcinoma of the bladder portend poor prognosis? A systematic review and meta-analysis
por: Chen, Qingke, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
por: Zhu, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iun61n2ggatb2mpkk9sulba02l